eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Hospira UK Ltd

Queensway, Royal Leamington Spa, Warwickshire, CV31 3RW
Telephone: +44 (0)1926 820 820
Fax: +44 (0) 1926 834446
WWW: http://www.hospira.com
Medical Information Direct Line: +44 (0) 1926 834400
Medical Information e-mail: medinfouk@hospira.com
Customer Care direct line: +44 (0)1926 821 022

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Summary of Product Characteristics last updated on the eMC: 14/05/2009
SPC Glyceryl Trinitrate 5 mg/ml Sterile Concentrate

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 14/05/2009 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   31-Dec-2007
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company






4.5     Interaction with other medicinal products and other forms of interaction

This section has changed. Interactions with anti-arrhythmics, anti-depressants and antimuscarinics which apply only to the ‘sublingual’ route of administration have been removed.

Sildenafil (Viagra):          sildenafil has known effects on the nitric oxide/cGMP pathway, and has been shown to potentiate the hypotensive effects of nitrates such as Glyceryl TrinitrateSterile Concentrate.

 

7.       MARKETING AUTHORISATION HOLDER.

 Name change

Hopsira UK Limited
Queensway

Royal Leamington Spa

Warwickshire,  CV31 3RW

 

10.     DATE OF REVISION OF THE TEXT

 Date of revision changed

31st December 2007

Updated on 24/02/2003 and displayed until 14/05/2009
Reasons for adding or updating:
  • Change to section 1 - trade name
  • Change to section 2 - qualitative and quantitative composition
  • Change to section 3 - pharmaceutical form
  • Change to section 6.1 - List of Excipients
  • Change to section 6.2 - Incompatibilities
  • Change to section 6. 3 - Shelf Life
  • Change to section 6. 4 - Special Precautions for Storage
  • Change to section 6. 5 - Nature and Contents of Container
  • Change to section 6. 6 - Instruction for Use/Handling
Updated on 16/07/2002 and displayed until 24/02/2003
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 02/07/2002 and displayed until 16/07/2002
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 12/06/2002 and displayed until 02/07/2002
Reasons for adding or updating:
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
Updated on 03/07/2001 and displayed until 12/06/2002
Reasons for adding or updating:
  • No reasons supplied
Updated on 06/09/1999 and displayed until 03/07/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   glyceryl trinitrate